Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study
Introduction: Bleeding occurs frequently in liver surgery. Unbalance between tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) concentrations might increase bleeding. Our aim was to analyze perioperative fibrinolytic changes during liver surgery.Materials and Methods:...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-09-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2018.00253/full |
id |
doaj-c7a9cb7892a146069ad3bf0e0fbdd15e |
---|---|
record_format |
Article |
spelling |
doaj-c7a9cb7892a146069ad3bf0e0fbdd15e2020-11-24T21:04:39ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2018-09-01510.3389/fmed.2018.00253399593Fibrinolytic System Changes in Liver Surgery: A Pilot Observational StudyAgnese Ozolina0Agnese Ozolina1Janis Nemme2Arturs Ozolins3Arturs Ozolins4Lars J. Bjertnæs5Indulis Vanags6Indulis Vanags7Janis Gardovskis8Janis Gardovskis9Ludmila Viksna10Angelika Krumina11Department of Anesthesiology, Orto Clinic, Riga, LatviaRiga Stradins University, Riga, LatviaDepartment of Anesthesiology and Intensive Care Unit, Pauls Stradins Clinical University Hospital, Riga, LatviaRiga Stradins University, Riga, LatviaDepartment of Surgery, Pauls Stradins Clinical University Hospital, Riga, LatviaAnesthesia and Critical Care Research Group, Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, NorwayRiga Stradins University, Riga, LatviaDepartment of Anesthesiology and Intensive Care Unit, Pauls Stradins Clinical University Hospital, Riga, LatviaRiga Stradins University, Riga, LatviaDepartment of Surgery, Pauls Stradins Clinical University Hospital, Riga, LatviaRiga Stradins University, Riga, LatviaRiga Stradins University, Riga, LatviaIntroduction: Bleeding occurs frequently in liver surgery. Unbalance between tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) concentrations might increase bleeding. Our aim was to analyze perioperative fibrinolytic changes during liver surgery.Materials and Methods: We evaluated 15 patients for inclusion into a prospective pilot study of liver surgery. We assessed fibrinolysis by plasma PAI-1 and t-PA: before surgery (T1), before Pringle maneuver (PM;T2), at the end of surgery (T3) and 24 h postoperatively (T4), and registered demographic and laboratory data, extent and duration of surgery, hemodynamic parameters, blood loss, and transfused volumes of blood products. Data presented as mean ± SD. Significance at P < 0.05.Results: After exclusion of six patients only undergoing biopsies, we included six women and three men aged 49.1 ± 19.6 years; two patients with liver metastases of colorectal cancer and hepatocellular carcinoma, respectively, two with focal nodular hyperplasia, two with hepatic hemangioma, and one with angiomyolipoma. Six patients underwent PM. PAI-1 plasma concentration (n = 9) rose from 6.25 ± 2.25 at T1 through 17.30 ± 14.59 ng/ml at T2 and 28.74 ± 20.4 (p = 0.007) and 22.5 ± 16.0 ng/ml (p = 0.04), respectively, at T3 and T4. Correspondingly, t-PA plasma concentration (n = 9) increased from 4.76 ± 3.08 ng/ml at T1 through 8.00 ± 5.10 ng/ml (p = 0.012) at T2 and decreased to 4.25 ± 2.29 ng/ml and 3.04 ± 3.09 at T3 and T4, respectively. Plasma t-PA level at T2 was significantly different from those at T1, T3, and T4 (p < 0.004). In PM patients, t-PA levels increased from T1, peaked at T2 (p = 0.001), and subsequently decreased at T3 and T4 (p = 0.011 and p = 0.037), respectively. Mean blood loss was 1,377.7 ± 1,062.8 ml; seven patients received blood products. Patients with higher PAI-1 levels at T3 received more fresh frozen plasma (r = 0.79; p = 0.01) and red blood cells (r = 0.88; p = 0.002).Conclusions: During liver surgery, fibrinolysis increased, as evidenced by rises in plasma PAI-1and t-PA, especially after start of surgery and following PM. Transfused volumes of blood products correlated with higher plasma concentrations of PAI-1. Confirming this tendency requires a larger cohort of patients.https://www.frontiersin.org/article/10.3389/fmed.2018.00253/fullfibrinolysisliver surgerytissue plasminogen activatort-PAplasminogen activator inhibitor type 1PAI-1 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Agnese Ozolina Agnese Ozolina Janis Nemme Arturs Ozolins Arturs Ozolins Lars J. Bjertnæs Indulis Vanags Indulis Vanags Janis Gardovskis Janis Gardovskis Ludmila Viksna Angelika Krumina |
spellingShingle |
Agnese Ozolina Agnese Ozolina Janis Nemme Arturs Ozolins Arturs Ozolins Lars J. Bjertnæs Indulis Vanags Indulis Vanags Janis Gardovskis Janis Gardovskis Ludmila Viksna Angelika Krumina Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study Frontiers in Medicine fibrinolysis liver surgery tissue plasminogen activator t-PA plasminogen activator inhibitor type 1 PAI-1 |
author_facet |
Agnese Ozolina Agnese Ozolina Janis Nemme Arturs Ozolins Arturs Ozolins Lars J. Bjertnæs Indulis Vanags Indulis Vanags Janis Gardovskis Janis Gardovskis Ludmila Viksna Angelika Krumina |
author_sort |
Agnese Ozolina |
title |
Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study |
title_short |
Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study |
title_full |
Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study |
title_fullStr |
Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study |
title_full_unstemmed |
Fibrinolytic System Changes in Liver Surgery: A Pilot Observational Study |
title_sort |
fibrinolytic system changes in liver surgery: a pilot observational study |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Medicine |
issn |
2296-858X |
publishDate |
2018-09-01 |
description |
Introduction: Bleeding occurs frequently in liver surgery. Unbalance between tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) concentrations might increase bleeding. Our aim was to analyze perioperative fibrinolytic changes during liver surgery.Materials and Methods: We evaluated 15 patients for inclusion into a prospective pilot study of liver surgery. We assessed fibrinolysis by plasma PAI-1 and t-PA: before surgery (T1), before Pringle maneuver (PM;T2), at the end of surgery (T3) and 24 h postoperatively (T4), and registered demographic and laboratory data, extent and duration of surgery, hemodynamic parameters, blood loss, and transfused volumes of blood products. Data presented as mean ± SD. Significance at P < 0.05.Results: After exclusion of six patients only undergoing biopsies, we included six women and three men aged 49.1 ± 19.6 years; two patients with liver metastases of colorectal cancer and hepatocellular carcinoma, respectively, two with focal nodular hyperplasia, two with hepatic hemangioma, and one with angiomyolipoma. Six patients underwent PM. PAI-1 plasma concentration (n = 9) rose from 6.25 ± 2.25 at T1 through 17.30 ± 14.59 ng/ml at T2 and 28.74 ± 20.4 (p = 0.007) and 22.5 ± 16.0 ng/ml (p = 0.04), respectively, at T3 and T4. Correspondingly, t-PA plasma concentration (n = 9) increased from 4.76 ± 3.08 ng/ml at T1 through 8.00 ± 5.10 ng/ml (p = 0.012) at T2 and decreased to 4.25 ± 2.29 ng/ml and 3.04 ± 3.09 at T3 and T4, respectively. Plasma t-PA level at T2 was significantly different from those at T1, T3, and T4 (p < 0.004). In PM patients, t-PA levels increased from T1, peaked at T2 (p = 0.001), and subsequently decreased at T3 and T4 (p = 0.011 and p = 0.037), respectively. Mean blood loss was 1,377.7 ± 1,062.8 ml; seven patients received blood products. Patients with higher PAI-1 levels at T3 received more fresh frozen plasma (r = 0.79; p = 0.01) and red blood cells (r = 0.88; p = 0.002).Conclusions: During liver surgery, fibrinolysis increased, as evidenced by rises in plasma PAI-1and t-PA, especially after start of surgery and following PM. Transfused volumes of blood products correlated with higher plasma concentrations of PAI-1. Confirming this tendency requires a larger cohort of patients. |
topic |
fibrinolysis liver surgery tissue plasminogen activator t-PA plasminogen activator inhibitor type 1 PAI-1 |
url |
https://www.frontiersin.org/article/10.3389/fmed.2018.00253/full |
work_keys_str_mv |
AT agneseozolina fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy AT agneseozolina fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy AT janisnemme fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy AT artursozolins fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy AT artursozolins fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy AT larsjbjertnæs fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy AT indulisvanags fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy AT indulisvanags fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy AT janisgardovskis fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy AT janisgardovskis fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy AT ludmilaviksna fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy AT angelikakrumina fibrinolyticsystemchangesinliversurgeryapilotobservationalstudy |
_version_ |
1716770358512582656 |